期刊文献+

基因编辑技术及其在中国的研究发展 被引量:15

Gene editing technology and its research progress in China
下载PDF
导出
摘要 基因编辑技术是一种能够对生物体的基因组及其转录产物进行定点修饰或者修改的技术,早期基因编辑技术包括归巢内切酶、锌指核酸内切酶和类转录激活因子效应物。近年来,以CRISPR/Cas9系统为代表的新型技术使基因编辑的研究和应用领域得以迅速拓展。本文对基因编辑技术的原理、技术发展及其应用进行了阐述,对我国在基因编辑机制研究及技术发展、基因编辑动植物模型构建、基因治疗等领域的研究进展进行了回顾,并对基因技术的发展前景及趋势进行了展望。 Gene editing is a technology for precision modification of genome sequences or expressing transcripts.Early versions of such techniques include homing endonuclease,zinc finger endonuclease and transcription-like activator effectors.The CRISPR/Cas9 system has recently emerged as a powerful and versatile gene editing tool for a broad spectrum of applications.In this review,we discuss the recent development and applications of gene editing technology,and particularly focus on the progress in China,with the emphasis on mechanistic studies,development of new and extended technologies,the applications in animals,plants and the therapeutics.
作者 陈一欧 宝颖 马华峥 伊宗裔 周卓 魏文胜 Yiou Chen;Ying Bao;Huazheng Ma;Zongyi Yi;Zhuo Zhou;Wensheng Wei(School of Life Science,Peking University,Beijing 100871,China;Biomedical Pioneering Innovation Center,Peking University,Beijing 100871,China;Beijing Advanced Innovation Center of Genomics,Beijing 100871,China;PKU-Tsinghua Center for Life Sciences,Beijing 100871,China;Academy for Advanced Interdisciplinary Studies,Peking University,Beijing 100871,China;Peking University Genome Editing Research Center,Beijing 100871,China)
出处 《遗传》 CAS CSCD 北大核心 2018年第10期900-915,共16页 Hereditas(Beijing)
基金 国家自然科学基金项目(编号:31430025)资助~~
关键词 基因编辑 遗传工程 CRISPR 基因功能 疾病模型 基因治疗 gene editing genetic engineering CRISPR gene function disease model gene therapy
  • 相关文献

参考文献11

二级参考文献55

  • 1何军,马志卿,张兴.植物源农药概述[J].西北农林科技大学学报(自然科学版),2006,34(9):79-85. 被引量:86
  • 2Spitz F, Furlong EE. Transcription factors: from enhancerbinding to developmental control. Nat Rev Genet 2012; 13:613-626.
  • 3Blancafort P, Segal D J, Barbas CF 3rd. Designing transcription factor architectures for drug discovery. Mol Pharmacol 2004; 66:1361-1371.
  • 4Sera T. Zinc-finger-based artificial transcription factors and their applications. Adv Drug Deliv Rev 2009; 61:513-526.
  • 5Beerli RR, Segal D J, Dreier B, Barbas CF 3rd. Toward control- ling gene expression at will: specific regulation of the erbB- 2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc Natl Acad Sci USA 1998; 95:14628-14633.
  • 6Beerli RR, Dreier B, Barbas CF 3rd. Positive and negative regulation of endogenous genes by designed transcription fac- tors. Proc NatI Acad Sci USA 2000; 97:1495-1500.
  • 7Zhang F, Cong L, Lodato S, Kosuri S, Church GM, Arlotta P. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol 2011; 29:149-153.
  • 8Moscou M J, Bogdanove AJ. A simple cipher governs DNA recognition by TAL effectors. Science 2009; 326:1501.
  • 9Boch J, Scholze H, Schornack S, et al. Breaking the code of DNA binding specificity of TAL-type IIl effectors. Science 2009; 326:1509-1512.
  • 10Maeder ML, Linder S J, Reyon D, et al. Robust, synergistic regulation of human gene expression using TALE activators. Nat Methods 2013; 10:243-245.

共引文献847

同被引文献174

引证文献15

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部